Deals > All

East Germany North Germany South Germany West Germany Austria Germany Switzerland [ # 12 & 35 ]

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5542 | Ordered by Date (descending)
1 2 3 ... 30 31 32 ... 54 55 56

Deal: Collaboration or Financing	Date
Metamark Genetics–Definiens: image analysis s/w, 201311– collab + supply multi-year agreem to use Cognition Network Technology with ProMark test	2013-11-20
CI3 Cluster–AbbVie: personalised immunotherapy, 201311 collab existent AbbVie Deutschland GmbH & Co KG is cluster partner	2013-11-19
CI3 Cluster–Bayer: personalised immunotherapy, 201311 collab existent Bayer Vital GmbH is cluster partner	2013-11-19
CI3 Cluster–Biopharm: personalised immunotherapy, 201311 collab existent PW Technologies GmbH is cluster partner	2013-11-19
CI3 Cluster–Dr Falk Pharma: personalised immunotherapy, 201311 collab existent Dr Falk Pharma GmbH is cluster partner	2013-11-19
CI3 Cluster–GenXPro: personalised immunotherapy, 201311 collab existent GenXPro GmbH is cluster partner	2013-11-19
CI3 Cluster–Infraserv Höchst: personalised immunotherapy, 201311 collab existent Infraserv GmbH & Co Hoechst KG is cluster partner	2013-11-19
CI3 Cluster–itechpartners: personalised immunotherapy, 201311 collab existent itechpartners – Dr Rainer Wessel is cluster partner	2013-11-19
CI3 Cluster–Medatixx: personalised immunotherapy, 201311 collab existent Medatixx GmbH & Co KG is cluster partner	2013-11-19
CI3 Cluster–Medesso: personalised immunotherapy, 201311 collab existent Medesso GmbH is cluster partner	2013-11-19
CI3 Cluster–Molekularpathologie Trier: personalised immunotherapy, 201311 collab existent ProteoPath GbR is cluster partner	2013-11-19
CI3 Cluster–thinXXS Microtechnology: personalised immunotherapy, 201311 collab existent thinXXS Microtechnology AG is cluster partner	2013-11-19
Scopis–High-Tech Gründerfonds: investment, 201311 financing round Series A incl returning investor HTGF	2013-11-19
Scopis–SEVERAL: investment, 201311 financing round Series A from HTGF + VC Fonds Technologie Berlin + Falk Strascheg + Fraunhofer	2013-11-19
Cambridge Bioscience–InSphero: cell culture technology, 201311– distribution excl of InSphero 3D cell culture products + services in the UK	2013-11-18
Strüngmann Group–SEVERAL: investment, 201311 Ganymed financing round Series E €45m from existing investors ATS + MIG Fond + FCPB Gany GmbH	2013-11-18
CSM Instruments–Anton Paar: investment, 201311 acquisition of CSM Instruments SA	2013-11-15
Merck (DE)–BeiGene: cancer drug, 201311– license ww + collab co-developm + commercialisation of PARP inhibitor BeiGene-290 by Merck Serono	2013-11-13
Qiagen–Maverix Biomics: bioinformatics, 201311– collab €na product integration + co-marketing of Ingenuity iReport + Maverix Analytic Platform	2013-11-13
R-Biopharm–Candor Bioscience: immunoassays, 201311– strategic alliance in the area of companion diagnostics	2013-11-13
Roche–Immatics: cancer immunotherapy, 201311– strategic r+d collab €17m upfront + research funding + >€1b milestones to develop cancer vaccines	2013-11-13
Coral BioNet–Wacker: investment, 201311– acquisition 100% of Scil Proteins Production GmbH by Wacker Biotech GmbH from BioNet Ventures GmbH	2013-11-12
MeVis–PERSON: investment, 201311 shareholding of voting rights of Carl JG Evertsz has fallen to 14.995%	2013-11-11
Novartis–Grifols: investment, 201311–201401 acquisition $1.675b of blood transfusion diagnostis unit by Grifols	2013-11-11
JnJ–Evotec: drug discovery services, 201311– collab drug target discovery for Alzheimer drugs with JnJ Innovation Centre California	2013-11-08
Auven Therapeutics–Five Prime: human antibodies, 201311– license excl €na to develop cancer ADCs to ADC Therapeutics	2013-11-05
Biocartis–SEVERAL: investment, 201311 financing round Series E €30m from existing investors	2013-11-05
Midatech–SEVERAL: investment, 201311 financing round £10m led by Ippon Capital SA with £7.6m plus existing investors	2013-11-05
Hookipa–BioMedPartners: investment, 201311 financing round Series B totalling €20m incl new + co-investor BioMedPartners	2013-11-04
Hookipa–Boehringer: investment, 201311 financing round Series B totalling €20m incl new + co-investor BIVF	2013-11-04
Hookipa–Forbion: investment, 201311 financing round Series B totalling €20m incl co-lead + returning investor Forbion Capital Partners	2013-11-04
Hookipa–SEVERAL: investment, 201311 financing round Series B €20m led by Sofinnova Partners + Forbion Capital Partners	2013-11-04
Hookipa–Sofinnova: investment, 201311 financing round Series B totalling €20m incl co-lead + returning investor Sofinnova Partners	2013-11-04
Hookipa–Takeda: investment, 201311 financing round Series B totalling €20m incl new + co-investor Takeda Ventures	2013-11-04
Merck (DE)–Kadimastem: drug discovery services, 201311– collab MOU drug screening + discovery for neurodegenerative disesases Merck Serono	2013-11-04
Strüngmann Group–4SC: drug discovery services, 201311– collab discovery + optimis small molecule anti-infectives by 4SC Discovery+Crelux for AiCuris	2013-11-04
Thermo Fisher–Univ Utrecht: mass spectrometry, 201311– collab developm applications + appointm of A Makarov as Professor	2013-11-04
AlBioTex project–Germany (govt): grant, 201311– BMBF co-funding for research project on microbial production of biopolymers for medtech + textiles	2013-11-01
DISCO project–EU (govt): grant, 201311–201710 FP7 grant €6.5m to develop bioactive compound extraction procedures	2013-11-01
m2p-labs–SEVERAL: investment, 201311 3rd financing round Fidura Private Equity Fonds + HTGF	2013-11-01
CRM Clinical Trials–Venn Life Sciences: investment, 201310 acquisition €0.6m in shares ANNOUNCED	2013-10-31
IROA Technologies–Bruker Corp: mass spectrometer, 201310 supply existent IROA uses Bruker MS for metabolomics research	2013-10-31
Merck (DE)–Max Planck: drug discovery services, 201310– collab 5y strategic partnership of Merck Serono with Lead Discovery Center GmbH	2013-10-31
Ako med–Curetis: Unyvero system, 201310 distribution existent Ako med doo is distributor in countries of former Yugoslavia for system + cartridges	2013-10-30
BioLine (RU)–Curetis: Unyvero system, 201310 distribution existent BioLine LLC is Russian distribution partner for system + cartridges	2013-10-30
Sanofi–Genedata: bioinformatics, 201310– supply Genedata Biologics data management platform will be used for biologcics sreening	2013-10-30
BioChain–Epigenomics: molecular diagnostics, 201310– broad strategic collaboration expanding prior license agreement for China	2013-10-28
Cell Signaling Technology–RainDance: RainDrop Digital PCR System, 201310– distribution by BIOKÉ in Germany + Benelux	2013-10-28
Epigenomics–BioChain: investment, 201310 acquisition €0.94m ($1.3m) of 217.9k new shares as part of strategic collaboration	2013-10-28
Formycon–SEVERAL: investment, 201310–201312 capital increase €9.4m 1.257m new common shares €7.5/share to existing shareholders	2013-10-28
Genetrix (ES)–SEVERAL: investment, 201310 rights offering + private placement of Sygnis AG €2.7m with 1.02m new shares €2.65/share	2013-10-28
Hana Pharmaceuticals–Paion: remimazolam, 201310– license excl €1m upfront + €2m milestones + 10% royalties for dev + manuf + commerc in Korea	2013-10-28
Biotest–SEVERAL: credit, 201310– placing of €210m notes in different tranches to more than 70 investors	2013-10-24
Merck (DE)–Polyplus-transfection: transfection reagents, 201310– license + supply agreem €na for PEI-based transfection reagents incl PEIpro	2013-10-24
Polyplus-transfection–Image Box: public relations, 201310 service existent by Image Box PR	2013-10-24
Celesio–McKesson: investment, 201310– acquisition €6.1b with acqu of 50.01% shares from Haniel + cash tender offer for all remaining shares €23/share	2013-10-23
Chem Tech Research–Apeptico: proteomic database, 201310– license to Pepbase therapeutic protein database for C-TRI	2013-10-23
F-Star Alpha–F-Star: cancer drugs, 201310– license excl to FS102 + Fcab + mAb2 technologies against up to 22 cancer targets	2013-10-23
F-Star Alpha–SEVERAL: investment, 201401 financing round Series A €9.4m incl Atlas Venture + Aescap + TVM + SR One + MP Healthcare + MS Ventures	2013-10-23
Boehringer–Beactica: drug discovery services, 201310– collab expansion €na fragment-based drug discovery services for oncology-relevant kinases	2013-10-22
Finox–SEVERAL: investment, 201310 capital increase CHF22m incl CHF12m from majority shareholder Willy Michel + CHF10m from BV Group	2013-10-22
Heraeus–Curetis: molecular diagnostics, 201310 collab existent co-developm + co-marketing of Unyvero i60 ITI application	2013-10-22
Roche–Samsung: biopharmaceuticals, 201310– supply €na long-term strategic contract manufacturing agreem with Samsung BioLogics	2013-10-22
Zivak Technologies–Tecan: automated liquid handling, 201310 supply Cavro Omni Robot for use with clinical Dx HPLC + LC-MSMS systems	2013-10-22
AstraZeneca–Evotec: kidney disease drugs, 201310– license + collab agreem €na giving AZ access to selected series of molecules to treat CKD	2013-10-21
Clovis Oncology–Qiagen: molecular companion diagnostics, 201310– collab developm of therascreen EGFR RGQ PCR Kit for CO-1686	2013-10-21
Mérieux–MC Services: public relations, 201310 service existent for Transgene SA	2013-10-21
Austria (govt)–Biocom: publishing, 201310 supply service with regard to Vienna Life Science Report 2013/14 to LISAvienna by Biocom	2013-10-17
Biodesy–Roche: investment, 201310 financing round Series A totalling $15m incl Roche Venture Fund	2013-10-17
Biodesy–SEVERAL: investment, 201310 financing round Series A $15m from 5AM Ventures + Pfizer Venture Investments + Roche Venture Fund	2013-10-17
Boehringer–Vector Capital: drug discovery s/w, 201310– supply Certara D360 as drug discovery platform in Ridgefield + Biberach + Vienna	2013-10-17
Suzhou SJ Biomaterials–Scienion: print/spotting technology, 201310– distribution of Scienion products in China by Suzhou SJ Biomaterials Co Ltd	2013-10-17
Sygnature Discovery–Proteros: drug discovery services, 201310– collab strategic alliance to offer integrated services incl X-ray structure analysis	2013-10-17
Merck (DE)–Firefly BioWorks: miRNA research assays, 201310– distribution ww of SmartRNAPlex assay by EMD Millipore	2013-10-16
Photonics Healthcare–Bavaria (govt): investment, 201310 1st financing round led by HTGF + Bayern Kapital	2013-10-16
Photonics Healthcare–High-Tech Gründerfonds: investment, 201310 1st financing round led by HTGF + Bayern Kapital	2013-10-16
Photonics Healthcare–SEVERAL: investment, 201310 1st financing round led by HTGF + Bayern Kapital	2013-10-16
AstraZeneca–Auven Therapeutics: antibody-drug conjugates, 201310– collab of ADC Therapeutics and MedImmune which acquired Spirogen	2013-10-15
Auven Therapeutics–AstraZeneca: investment, 201310 acquisition 100% of Spirogen Ltd for $200m upfront + $240 milestones by MedImmune	2013-10-15
Auven Therapeutics–AstraZeneca: investment, 201310 investment $20m in ADC Therapeutics by MedImmune matched by majority shareholder Auven Therapeutics	2013-10-15
CV genes-at-target project–EU (govt): grant, 2013– FP7 grant €5.75m to investigate genomic risk loci for CAD + stroke	2013-10-15
CV genes-at-target project–Evotec: genomic drug target discovery, 2013– collab European ScreeningPort is partner in FP7 project	2013-10-15
CV genes-at-target project–Genedata: genomic drug target discovery, 2013– collab Genedata is partner in FP7 project	2013-10-15
CV genes-at-target project–Univ Lübeck: genomic drug target discovery, 2013– collab Univ of Lübeck is partner in FP7 project	2013-10-15
Immatics–SEVERAL: investment, 201310 financing round Series D 1st tranche €12m of €34m round Hopp + Strüngmann + Wellington Partners + MIG Funds	2013-10-15
Bayer–BioInvent: antibody library, 201310 license €na extension + broadening to n-CoDeR libraries for development of therapeutic antibodies	2013-10-14
Novartis–ImmunoGen: ADC technology, 201310– license to use technology against a cancer target under collab agreem from 2010	2013-10-11
Cytos Biotechnology–SEVERAL: investment, 201310–201311 capital increase CHF24.3m 8.1m shares CHF3/share to Abingworth + Amgen + venBio + Aisling et al	2013-10-10
Bayer–RWTH Aachen: bioinformatics, 201310– collab founding of Joint Research Center on Computational Biomedicine by BTS + RWTH	2013-10-09
Bayer–Sysmex: molecular companion diagnostics, 201310– collab master agreem for developm of blood-based CDx for cancer drugs by Sysmex Inostics	2013-10-09
Sartorius–PERSON: investment, 201310 existent family of the late Horst Satorius owns 50.09% bound by last will of Horst Satorius	2013-10-09
Schott–Sony: slides, 201310 collab developm + marketing of glass-plastic hybrid cell imaging slide	2013-10-07
JnJ–CureVac: vaccine technology, 201310– collab + license €na use of RNActive technology for developm of mRNA-based influenza vaccine with Crucell	2013-10-03
Merus–Akampion: public relations, 201310 service existent by Akampion	2013-10-03
Acino–Avista Capital: investment, 201310– public tender offer CHF398m with CHF115/share by Avista Capital Partners + Nordic Capital	2013-10-02
Acino–Nordic Capital: investment, 201310– public tender offer CHF398m with CHF115/share by Avista Capital Partners + Nordic Capital	2013-10-02
Acino–SEVERAL: investment, 201310– public tender offer CHF398m with CHF115/share by Avista Capital Partners + Nordic Capital	2013-10-02
Polymedco–Epigenomics: molecular diagnostics, 201310– collab joint commercialisation of Epi proColon test in North America	2013-10-02
Findeisen Laborbedarf–Omnilab (DE): investment, 201310 acquisition of Findeisen Laborbedarf GmbH by Omnilab-Laborzentrum GmbH & Co KG	2013-10-01
Innovative Medicines Initiative–EU (govt): grant, 201310– funding €8m for GETREAL project by IMI of €16.3m total cost	2013-10-01

1 2 3 ... 30 31 32 ... 54 55 56

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)